There are three major levers for pharmacies to consider for business survival during the coronavirus pandemic, say Bruce Annabel and Mal Scrymgeour Cometh the Hour is a truncation of an …

Pharmacists are dealing with a unique situation in the COVID-19 pandemic. Kay Dunkley from the Pharmacists’ Support Service describes some ways you can lessen the resultant stress, plus what you …

Australia’s chief medical officer has written an open letter to pharmacy about managing the flu season during the COVID-19 pandemic Dear Colleagues, As you would be aware from my recent …

Pharmacists are coming under attack from some patients, and it has to stop, says Catherine Bronger The COVID-19 crisis has once again seen community pharmacies rise to the occasion and …

Federal Health Minister Greg Hunt has written an open letter to the entire community pharmacy sector Dear pharmacists and community pharmacy staff, Let me start by thanking you for your …

With community pharmacy showing its worth in the bushfire disaster and being asked to step up during the ongoing coronavirus pandemic, why is the government willing to risk the network, …

In the second of a series, Kim Brotherson, Pharmacy 777 Managing Director, discusses five crucial objectives for the 7CPA In the first of this series, we looked at the scene …

In the first of a two-part series, Kim Brotherson, Pharmacy 777 Managing Director, looks at the key points we should be focusing on to build a sustainable future for community …

Put aged care support where it belongs, argues Guild NSW branch president David Heffernan in response to news of increased Home Medicine Review caps In its haste to be seen to be …

The ATO is increasing its application of justified trust reviews, and not just to the top end of town, says consultant Lauren Whelan The recent increase in flow of available …

Tony Hall, Esther Lau and Lisa Nissen take a look at the current state of play with medicinal cannabis Patient demand for medicinal cannabis is still growing. Currently, there are …

The Government’s current narrow focus on 60-day dispensing and the $1 discount is doing little to ease fears that universal access to medicines is under threat from its determination to …